Gam Holding Ag Innoviva, Inc. Transaction History

Gam Holding Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$8.11 - $15.23 $92,178 - $173,104	-11,366 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$10.28 - $14.38 $60,847 - $85,115	-5,919 Reduced 34.24%	11,366 $161,000
Q3 2019 Nov 08, 2019	SELL	$10.05 - $14.55 $351,790 - $509,308	-35,004 Reduced 66.94%	17,285 $182,000
Q2 2019 Aug 12, 2019	BUY	$13.1 - $14.95 $429,064 - $489,657	32,753 Added 167.65%	52,289 $761,000
Q1 2019 May 10, 2019	SELL	$13.69 - $20.06 $342,140 - $501,339	-24,992 Reduced 56.13%	19,536 $274,000
Q4 2018 Feb 08, 2019	SELL	$13.96 - $18.26 $102,717 - $134,357	-7,358 Reduced 14.18%	44,528 $761,000
Q3 2018 Nov 13, 2018	SELL	$13.63 - $15.7 $168,698 - $194,318	-12,377 Reduced 19.26%	51,886 $791,000
Q2 2018 Aug 09, 2018	BUY	$13.44 - $17.59 $249,110 - $326,030	18,535 Added 40.53%	64,263 $887,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $487,554 - $600,256	-35,330 Reduced 43.59%	45,728 $762,000
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $950,810 - $1.2 Million	81,058	81,058 $1.15 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.